Pain Therapeutics Summit 2013

This conference provides attendees with thoughtful insight from key industry leaders and academic researchers concerning cutting edge drug discovery science, preclinical development trends, analysis of key clinical-stage pain therapies and newly marketed products. We will highlight the most important developments in recent years in the field, including new research in genome-wide association studies, CGRP antagonists, NGF antagonists, sodium and calcium channel blockers, new research in biologic therapies, the genetic components of pain, abuse-resistant opioids, analysis of FDA’s REMS program and a plethora of other topics.

REASONS TO ATTEND
LEARN about the latest developments and the most recent commercial breakthroughs in the area of pain therapeutics

GAIN a better sense of the impact the biotech industry is having on the development of pain therapeutics

DISCOVER what innovative new therapies are driving investment and clinical development in the area of pain therapeutics

NETWORK with leaders from the pharma, biotech, specialty pharma and drug delivery industries as well as the academic community and government

BETTER UNDERSTAND the specific and implications of groundbreaking new research in the field of pain therapeutics

ACQUIRE a holistic view of the field of pain therapeutics from the perspective of scientists, clinicians and commercial executives